Orphazyme A/S - ESG Rating & Company Profile powered by AI
This page is a free E,S&G assessment for Orphazyme A/S. This Disclosure score covers seventeen United Nations Sustainable Development Goals including: 'Quality Education', 'Climate Action' and 'Life below Water'. This report of Orphazyme A/S was assembled by All Street Sevva using leading AI.
Orphazyme A/S in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 5.3, social score of 1.6 and governance score of 8.0.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 724 | Skye Bioscience Inc | 5.1 | High |
| 724 | Xbrane Biopharma AB | 5.1 | High |
| 744 | Orphazyme A/S | 5.0 | High |
| 744 | CSL Ltd | 5.0 | High |
| 744 | CStone Pharmaceuticals | 5.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Orphazyme A/S have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Orphazyme A/S disclose current and historical energy intensity?
Sign up for free to unlockDoes Orphazyme A/S report the average age of the workforce?
Sign up for free to unlockDoes Orphazyme A/S reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Orphazyme A/S disclose its ethnicity pay gap?
Sign up for free to unlockDoes Orphazyme A/S disclose cybersecurity risks?
Sign up for free to unlockDoes Orphazyme A/S offer flexible work?
Sign up for free to unlockDoes Orphazyme A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Orphazyme A/S disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Orphazyme A/S conduct supply chain audits?
Sign up for free to unlockDoes Orphazyme A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Orphazyme A/S conduct 360 degree staff reviews?
Sign up for free to unlockDoes Orphazyme A/S disclose the individual responsible for D&I?
Sign up for free to unlockDoes Orphazyme A/S disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Orphazyme A/S disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Orphazyme A/S disclose water use targets?
Sign up for free to unlockDoes Orphazyme A/S have careers partnerships with academic institutions?
Sign up for free to unlockDid Orphazyme A/S have a product recall in the last two years?
Sign up for free to unlockDoes Orphazyme A/S disclose incidents of discrimination?
Sign up for free to unlockDoes Orphazyme A/S allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Orphazyme A/S issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Orphazyme A/S disclose parental leave metrics?
Sign up for free to unlockDoes Orphazyme A/S disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Orphazyme A/S disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Orphazyme A/S disclose the pay ratio of women to men?
Sign up for free to unlockDoes Orphazyme A/S support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Orphazyme A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Orphazyme A/S reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Orphazyme A/S involved in embryonic stem cell research?
Sign up for free to unlockDoes Orphazyme A/S disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Orphazyme A/S disclose its waste policy?
Sign up for free to unlockDoes Orphazyme A/S report according to TCFD requirements?
Sign up for free to unlockDoes Orphazyme A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Orphazyme A/S disclose energy use targets?
Sign up for free to unlockDoes Orphazyme A/S disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Orphazyme A/S have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Orphazyme A/S
These potential risks are based on the size, segment and geographies of the company.
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is the Arimoclomol, which is in clinical development for diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, and Inclusion Body Myositis. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.